SEC Form D · Amendment · filed October 2, 2018
Genomind, Inc
Industry
Other Health Care
Location
King of Prussia, PA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Joseph E. Anton · Boston, MADirectorGloria E. Nuss · Norfolk, VAExecTheresa E. Sexton · Nashville, TNDirectorRonald I. Dozoretz · Norfolk, VAExec · Director · PromoterJohn E. Chadwick · Nashville, TNDirectorRina E. Wolf · Valencia, CADirectorThomas E. Hess · King of Prussia, PAExecStephen E. Haller · Norfolk, VAExecBeth E. Dozoretz · Norfolk, VAExec · DirectorMichael I. Koffler · Chalfont, PADirectorRail-Splitter Capital Management, LLC · Chicago, ILDirectorPhalanx Capital GP, LLC · Chicago, ILExec · DirectorPCM Capital Select Managers Fund LLC · Kansas City, MODirectorIgnacio N. Tzoumas · Miami Beach, FLDirectorR. L. Priest, Jr · Williamsburg, VADirectorHoward S. Silverman · OMAHA, NEExec · Director · PromoterRobert A. Dean · OMAHA, NEExec · DirectorDouglas L. Dethy · New York, NYExec · DirectorDouglas B. Dunn · Houston, TXExec · Director · PromoterPCM Capital Managed Equity Fund I LLC · Kansas City, MOExecAugusto Alvarez · Santa Fe, O5ExecDavid Riker · New York, NYDirectorJonathan Budd · DEL MAR, CAExecDan A. Westbrook · Oklahoma City, OKDirectorXin Yi · Hong Kong, Hong KongDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗